- Home
- EVTV vs PPBT Comparison
EVTV vs PPBT Comparison
Compare EVTV & PPBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EVTV
- PPBT
- Stock Information
- Founded
- EVTV 2012
- PPBT 2010
- Country
- EVTV United States
- PPBT Israel
- Employees
- EVTV N/A
- PPBT N/A
- Industry
- EVTV Auto Manufacturing
- PPBT Biotechnology: Pharmaceutical Preparations
- Sector
- EVTV Consumer Discretionary
- PPBT Health Care
- Exchange
- EVTV Nasdaq
- PPBT Nasdaq
- Market Cap
- EVTV 6.2M
- PPBT 6.5M
- IPO Year
- EVTV 2017
- PPBT N/A
- Fundamental
- Price
- EVTV $0.25
- PPBT $2.27
- Analyst Decision
- EVTV
- PPBT Strong Buy
- Analyst Count
- EVTV 0
- PPBT 1
- Target Price
- EVTV N/A
- PPBT $33.00
- AVG Volume (30 Days)
- EVTV 412.7K
- PPBT 286.5K
- Earning Date
- EVTV 05-27-2025
- PPBT 05-23-2025
- Dividend Yield
- EVTV N/A
- PPBT N/A
- EPS Growth
- EVTV N/A
- PPBT N/A
- EPS
- EVTV N/A
- PPBT N/A
- Revenue
- EVTV $1,870,060.00
- PPBT N/A
- Revenue This Year
- EVTV N/A
- PPBT N/A
- Revenue Next Year
- EVTV N/A
- PPBT N/A
- P/E Ratio
- EVTV N/A
- PPBT N/A
- Revenue Growth
- EVTV N/A
- PPBT N/A
- 52 Week Low
- EVTV $0.23
- PPBT $2.00
- 52 Week High
- EVTV $2.61
- PPBT $20.60
- Technical
- Relative Strength Index (RSI)
- EVTV 46.47
- PPBT 40.43
- Support Level
- EVTV $0.23
- PPBT $2.18
- Resistance Level
- EVTV $0.28
- PPBT $2.41
- Average True Range (ATR)
- EVTV 0.02
- PPBT 0.20
- MACD
- EVTV 0.00
- PPBT -0.01
- Stochastic Oscillator
- EVTV 38.25
- PPBT 27.96
About EVTV Envirotech Vehicles Inc.
Envirotech Vehicles Inc is a provider of purpose-built zero-emission electric vehicles focused on reducing the total cost of vehicle ownership and helping fleet operators unlock the benefits of green technology. It recognizes revenue from the sales of zero-emission electric vehicles and vehicle maintenance and inspection services. The Company serves commercial and last-mile fleets, school districts, public and private transportation service companies and colleges and universities to meet the increasing demand for light to heavy-duty electric vehicles.
About PPBT Purple Biotech Ltd.
Purple Biotech Ltd is a clinical-stage company focused on advancing first-in-class therapies to overcome tumor immune evasion and drug resistance, and to create treatments for people with cancer. Its oncology pipeline includes NT219: A dual inhibitor, small molecule that simultaneously targets Insulin Receptor Substrate 1 and 2 (IRS1/2) and Signal Transducer and Activator of Transcription (STAT3), two survival signal transduction pathways driving the development of cancer drug resistance. and CM24: is a humanized monoclonal antibody designed to block the interactions of Carcinoembryonic Antigen Related Cell Adhesion Molecule 1 (CEACAM1), a glycoprotein that plays a key role in immune regulation, cell adhesion, and tumor progression, CAPTN3.